Table 3.
Association between exposure to oral bisphosphonates and atrial fibrillation
| Cases n = 726 (%) |
Controls n = 7260 (%) |
Crude OR (95 % CI) |
Adjusted OR (95 % CI) |
|
|---|---|---|---|---|
| Current | 373 (51) | 3129 (43) | 1.71 (1.41–2.08) | 1.78 (1.46–2.16) |
| Recent | 78 (11) | 667 (09) | 1.68 (1.26–2.23) | 1.70 (1.27–2.28) |
| Past | 96 (13) | 1006 (14) | 1.38 (1.06–1.80) | 1.41 (1.07–1.85) |
| Distant past | 179 (25) | 2458 (34) | Reference | Reference |
Adjusted for angina pectoris, heart failure, antihypertensive drugs, myocardial infarction, use of lipid lowering drugs, oral corticosteroids, and antithyroid drugs. Categories of users: current (0–90 days prior to index date), recent (91–180 days), past (181–365 days), and distant past (365+ days)
CI confidence interval, OR odds ratio